|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
Engels
|
DCEG (NCI)
|
|
1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who
|
Z01 BC 010581
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
A Drosophila Model for MEN2 and Sporadic MTCs
|
5R01CA084309-07
|
$212,392
|
Cagan, Ross
|
WASHINGTON UNIVERSITY
|
|
A Mutational Model for Childhood Cancer
|
5P01CA034936-20
|
$2,711,787
|
STRONG, LOUISE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A novel set of molecular markers to measure metastatic neuroblastoma
|
5R21CA118845-02
|
$132,978
|
CHEUNG, NAI-KONG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric
|
Z01 BC 010584
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
A Web-Based Smoking Intervention for Cancer Survivors
|
5R01CA106914-04
|
$558,648
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Acquired Resistance to VEGF blockade in Wilms tumor
|
5R01CA100451-05
|
$310,442
|
KANDEL, JESSICA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
Aplan, Peter
|
CCR (NCI)
|
|
American College of Radiology Imaging Network
|
5U01CA080098-09
|
$10,637,601
|
HILLMAN, BRUCE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
Z01 BC 010709
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
An investigation of radial glia as the source of ependymoma stem cells
|
1R01CA129541-01
|
$313,500
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Antifolate Resistance in Osteosarcoma
|
5R01CA083132-07
|
$149,529
|
GORLICK, RICHARD
|
YESHIVA UNIVERSITY
|
|
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,324,087
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Antileukemic effort of NK cells in HCT for pediatric AML
|
1R01CA120583-01A2
|
$359,055
|
LEUNG, WING
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS
|
5R01CA077683-08
|
$266,610
|
Felix, Carolyn
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma
|
5R01CA082274-08
|
$285,459
|
Harrington, William
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Apoptotic Pathway Defects in Neuroblastoma
|
5R01CA067938-11
|
$320,011
|
LAHTI, JILL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Application of genomic approaches to classify retinoblastoma tumors
|
1R21CA123196-01A1
|
$190,549
|
GANGULY, ARUPA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Aspirin use, genetic variation in aspirin related-genes, and Hodgkin lymphoma ris
|
1R03CA130048-01
|
$72,500
|
Chang, Ellen
|
NORTHERN CALIFORNIA CANCER CENTER
|
|
Astrocytic Cancers: How, When, Where?
|
5U01CA084314-09
|
$1,087,426
|
VAN DYKE, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Basis of PAX3-FKHR oncogenesis in rhabdomyosarcoma
|
2R01CA074907-10A1
|
$301,063
|
WANG, CHIAYENG
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-06
|
$1,030,000
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
bHLH Factors in Medulloblastoma Genesis and Maintenance
|
5R01CA112350-03
|
$310,300
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biochemistry of Leukemia Virus Core Binding Factor
|
5R01CA058343-14
|
$405,444
|
SPECK, NANCY
|
DARTMOUTH COLLEGE
|
|
Biology and Prognostic implications of Flt3 mutations in AML
|
5R01CA114563-03
|
$421,364
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-08
|
$1,899,503
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biostatistics and Data Management Section
|
Z01 SC 007202
|
$506,426
|
Steinberg, Seth
|
CCR (NCI)
|
|
Body size and breast cancer risk in a multiethnic population
|
5R03CA121875-02
|
$68,504
|
JOHN, ESTHER
|
NORTHERN CALIFORNIA CANCER CENTER
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
2P01CA049605-19
|
$3,353,514
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
2P01CA015396-32A1
|
$2,857,642
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Brain tumor angiogenesis: Integrin ceramide signaling
|
5R01CA098568-04
|
$266,432
|
ERDREICH-EPSTEIN, ANAT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
BRG1/BRM: role in RB tumor suppressor signaling
|
5R01CA104213-04
|
$238,696
|
KNUDSEN, ERIK
|
UNIVERSITY OF CINCINNATI
|
|
BWS and Embryonal Tumor Suppressor Genes on 11p15
|
5R37CA054358-17
|
$433,460
|
FEINBERG, Andrew
|
JOHNS HOPKINS UNIVERSITY
|
|
Camptothecin Analogs for Cancer Therapy
|
1R43CA125871-01A1
|
$158,895
|
MORGAN, LEE
|
DEKK-TEC, INC.
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S2
|
$108,416
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S3
|
$113,053
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
5P30CA016042-33
|
$4,541,766
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
3P30CA016086-32S1
|
$89,905
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-32
|
$6,392,142
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-32S1
|
$112,121
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-32S2
|
$71,869
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-32S3
|
$113,250
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
5P30CA016672-32
|
$9,167,196
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|